TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp. (TNXP) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: August 20, 2026 , by BAGGER RICHARD H .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| BAGGER RICHARD H | Director | Buy | 1,000 | $12.60 | $12.6K | 1,000 | |
| Taylor Carolyn E. | Director | Buy | 1,415 | $10.55 | $14.9K | 1,833 | |
| LEDERMAN SETH | Chief Executive Officer | Buy | 5,000 | $11.79 | $59.0K | 9,005 | |
| Stillwell Richard Newcomb | Director | Buy | 5,000 | $11.65 | $58.3K | 5,000 | |
| LEDERMAN SETH | Chief Executive Officer | Buy | 5,000 | $12.62 | $63.1K | 20,001 | |
| LEDERMAN SETH | Chief Executive Officer | Buy | 15,000 | $14.89 | $223.4K | 15,001 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.